Graduate Seminars The Bayer Distinguished Lectureship 1999 Dr. John Deutch has served in significant government and academic posts throughout his career. In May 1995, he was sworn in as Director of Central Intelligence following a unanimous vote in the Senate, and served as DCI until December 1996. In this position, he was head of the Intelligence Community (all foreign intelligence agencies of the United States) and directed the Central Intelligence Agency. From March 1994 to May 1995, he served as the Deputy Secretary of Defense. From March 1993 to March 1994, Dr. Deutch served as Under Secretary of Defense for Acquisitions and Technology. From 1977 to 1980, Dr. Deutch served in a number of positions for the U.S. Department of Energy: as Director of Energy Research, Acting Assistant Secretary for Energy Technology, and Undersecretary of the Department. Dr. Deutch has served on many commissions during several presidential administrations, and has received fellowships and honors from the American Academy of Arts and Sciences (1978) and Alfred P. Sloan (Research Fellow 1967-69), and John Simon Guggenheim (Memorial Fellow 1974-1975). Public Service Medals have been awarded him from the Department of Energy (1980), the Department of State (1980), the Department of Defense (1994), the Department of the Army (1995), the Department of the Navy (1995), the Department of the Air Force (1995), the Coast Guard (1995), the Central Intelligence Distinguished Intelligence Medal (1996) and the Intelligence Community Distinguished Intelligence Medal (1996). From 1970 to the present, Dr. Deutch has been a member of the faculty of the Massachusetts Institute of Technology, where he has served as Chairman of the Department of Chemistry, Dean of Science and Provost. Currently, Dr. Deutch is an MIT Institute Professor. Dr. Deutch earned a B.A. in history and economics from Amherst College, and both the B.S. in chemical engineering and Ph.D. in physical chemistry from M.I.T. He holds honorary degrees from Amherst College, University of Lowell and Northeastern University. Dr. Deutch serves as director for the following publicly held companies: Ariad Pharmaceutical, Citicorp, CMS Energy, Cummins, Sandia and Schlumberger Ltd. Dr. Deutch's achievements make him an ideal recipient of the Bayer Distinguished Lectureship for 1999. LecturesFebruary 18, 1999Frick Fine Arts Auditorium5 pm Lecture6 pm ReceptionThe World Security Outlook What are the leading security concerns on the world agenda? How well are the United States and other nations equipped to deal with these concerns? My thesis is that, after an optimistic period following the end of the Cold War when the world moved towards democracy and market economies, we are now in a period when there are too many issues on the agenda relative to the world's capacity for dealing with these issues. I will review the list of issues briefly and discuss only one issue at any length -- the growing threat of catastrophic terrorism. February 19, 19991175 Benedum Engineering Hall 11:00 am LectureChanges in How the Country Performs R & D During the past several years there has been a paradigm shift in how this country pursues research, development, and innovation. In part, the change is due to the explosion of information technology in its many forms; in part it is due to concerns about the relative competitiveness of the US that arose in the late eighties. I will discuss this transition from a centralized and linear system to a decentralized and parallel system of innovation in US industry. The implications of this change on federal government support of R&D and of university research and education will also be addressed. The Bayer Distinguished LectureshipBayer Corporation is a research-based company with major businesses in health care and life sciences, chemicals and imaging technologies. The company had 1997 sales of $9.3 billion and employs more than 26,000 people. Bayer Corporation is investing $9 billion in capital expenditures and research and development from 1995 through the year 2000. 1998 capital investment and R&D expenditures are projected to total $1.7 billion. Bayer Corporation, with headquarters in Pittsburgh, is a member of the worldwide Bayer Group, a $32 billion chemical and pharmaceutical company based in Leverkusen, Germany. The longstanding relationship between Bayer Corporation and the Department of Chemical and Petroleum Engineering at the University of Pittsburgh has resulted in the sponsorship of the Bayer Distinguished Lecture Series. |
Seminars Archive
News |
Benedum Hall
Dedicated in 1971, Benedum Hall is home to exploration and discovery.
You are using a browser that does not support current Web standards. Although this site is viewable in all browsers, it will look much better in a browser that supports Web standards.